A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers
about
Kynurenines in CNS disease: regulation by inflammatory cytokinesUnderstanding the somatic consequences of depression: biological mechanisms and the role of depression symptom profileCelecoxib Adjunctive Treatment to Antipsychotics in Schizophrenia: A Review of Randomized Clinical Add-On TrialsIs there Progress? An Overview of Selecting Biomarker Candidates for Major Depressive DisorderPathogenetic and Therapeutic Applications of Tumor Necrosis Factor-α (TNF-α) in Major Depressive Disorder: A Systematic ReviewStaging Models in Bipolar Disorder: A Systematic Review of the LiteratureThe Neurobiology of Bipolar Disorder: An Integrated ApproachDepression and frailty in later life: a systematic reviewStress-Related Immune Markers in Depression: Implications for TreatmentNeuroinflammation and comorbidities are frequently ignored factors in CNS pathologyInflammation and immunity in schizophrenia: implications for pathophysiology and treatmentFuture Directions for Pharmacotherapies for Treatment-resistant Bipolar DisorderBeyond Monoamines-Novel Targets for Treatment-Resistant Depression: A Comprehensive ReviewChallenging Treatment-Resistant Major Depressive Disorder: A Roadmap for Improved TherapeuticsThe Involvement of TNF-α in Cognitive Dysfunction Associated with Major Depressive Disorder: An Opportunity for Domain Specific TreatmentsPharmacological approaches to the challenge of treatment-resistant depressionGlial abnormalities in substance use disorders and depression: does shared glutamatergic dysfunction contribute to comorbidity?The cytokine model of schizophrenia: emerging therapeutic strategiesInflammation and schizophreniaThe vascular depression hypothesis: mechanisms linking vascular disease with depressionChemobrain: a critical review and causal hypothesis of link between cytokines and epigenetic reprogramming associated with chemotherapyRisk assessment and predicting outcomes in patients with depressive symptoms: a review of potential role of peripheral blood based biomarkersLow-dose lipopolysaccharide (LPS) inhibits aggressive and augments depressive behaviours in a chronic mild stress model in mice.Neuroinflammation at the interface of depression and cardiovascular disease: Evidence from rodent models of social stressNeuroimmune mechanisms of depressionImmune and Neuroendocrine Mechanisms of Stress Vulnerability and ResilienceConceptual convergence: increased inflammation is associated with increased basal ganglia glutamate in patients with major depressionThe Depressed Frail Phenotype: The Clinical Manifestation of Increased Biological Aging.The Microbiota, Immunoregulation, and Mental Health: Implications for Public Health.Association of CRP genetic variation and CRP level with elevated PTSD symptoms and physiological responses in a civilian population with high levels of traumaAdult neurogenesis and mental illness.Cytokine gene variations associated with subsyndromal depressive symptoms in patients with breast cancerQuest for biomarkers of treatment-resistant depression: shifting the paradigm toward risk.Feasibility of investigating differential proteomic expression in depression: implications for biomarker development in mood disorders.Quantitative Magnetization Transfer Imaging as a Biomarker for Effects of Systemic Inflammation on the Brain.Vagus Nerve Stimulation.Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants.Inflammatory and metabolic dysregulation and the 2-year course of depressive disorders in antidepressant usersResilience and Vulnerability to Pain and Inflammation in the Hippocampus.Altered peripheral immune profiles in treatment-resistant depression: response to ketamine and prediction of treatment outcome.
P2860
Q21129356-BBAF905F-F3E6-4907-98DD-B9EA4E291036Q21245293-DDD69115-4732-428F-8A95-14E3C6CA2A2FQ26741541-D3833FFB-FD83-4836-AB73-AA6F7DEA82C2Q26747511-0E5CCBAA-1A99-4190-BCFA-D9E355FBA5FEQ26749017-0012B854-9A5E-49D8-9AC0-09AD56FA2F8EQ26749336-D98E9F10-CC05-4911-B992-30C2949A8278Q26766633-060B0FE1-7ABC-4A0F-9BCE-15673EC90329Q26771517-86C436BD-1417-4717-8F56-082A911E489DQ26771607-0E453770-6EF9-4FB3-9EF2-D950C570ED21Q26775794-3104786C-E190-49D4-BC07-0FD08E00F21CQ26781620-6E60AD0B-8C4A-4FF4-9D35-1D001D260DAFQ26782989-1E171467-DB2C-48B1-A07C-B4D66F2E8906Q26782993-04D76918-0D9A-4AD1-912F-F4CE7B193B71Q26782997-DE9343F7-27E7-456E-B67E-02DB194E283FQ26783012-5C7536F5-4261-4FED-B1AB-F4C93C99A89EQ26798241-44F506A7-B1A7-402C-B45A-0305932B20BEQ26829556-1375D29B-AA8B-4A23-8BB6-A103C416BE2DQ26865996-95E29DF5-04DB-4E09-A641-B0558E828096Q27002489-292BECDD-1EA6-44C1-BD64-73DD10566949Q27010321-BC539AB8-F34F-4FA9-946D-BE988AE277BFQ27011451-3A0F98E0-E830-4B36-8F07-4AAA442F29E5Q27023402-B44C46CD-9D7A-4DC8-AE54-5A8793359DE2Q27303137-A93A930D-7A87-474B-9D15-D5C68CD68373Q28069771-382C6F27-5140-497E-8800-52DC6D4FE956Q28084450-A0421525-8A08-40FA-A49B-E4E16E7E9F3BQ28396103-69F3EF48-08A4-4E21-B19D-34FE7DB2BADBQ28830670-AA9B9B4E-8670-4AC8-85C2-9C7F9FD7429EQ30244442-77D7BA08-C3F2-4529-99DF-A445A9474660Q30248903-534BFE61-51E8-4D9F-8013-587E362D3542Q30386886-E58CF7D5-9C6A-4B15-83F2-A5BE053700BEQ30395004-04AF875C-2A35-461F-9D6B-3B073326F570Q30581961-5742A7D8-D637-44DC-8443-AA1C1201370DQ30650490-39F4DF56-D4E9-4305-89BC-18D22224EE7CQ30823738-B7010EC1-7ACA-4BCC-9ECD-A290508C065CQ30881223-8D85096F-8FCD-402D-BA21-8D9DA8BF12B8Q33595296-2D5441BD-124C-4952-B072-96BEEBD9DD49Q33604879-F3C77752-9576-4888-90D3-AE88E5E526D0Q33620656-443D574A-DA53-40BE-AFDB-F97FF4582FB6Q33624442-F8D6CF0D-B4B9-4079-8AA9-823A41001B22Q33635571-975F5531-7F2A-4D3D-BC54-29B1C5430D78
P2860
A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
A randomized controlled trial ...... seline inflammatory biomarkers
@ast
A randomized controlled trial ...... seline inflammatory biomarkers
@en
A randomized controlled trial ...... eline inflammatory biomarkers.
@nl
type
label
A randomized controlled trial ...... seline inflammatory biomarkers
@ast
A randomized controlled trial ...... seline inflammatory biomarkers
@en
A randomized controlled trial ...... eline inflammatory biomarkers.
@nl
prefLabel
A randomized controlled trial ...... seline inflammatory biomarkers
@ast
A randomized controlled trial ...... seline inflammatory biomarkers
@en
A randomized controlled trial ...... eline inflammatory biomarkers.
@nl
P2093
P2860
P1433
P1476
A randomized controlled trial ...... seline inflammatory biomarkers
@en
P2093
Andrew H Miller
Charles L Raison
Daniel F Drake
Pamela Schettler
Robin E Rutherford
P2860
P356
10.1001/2013.JAMAPSYCHIATRY.4
P407
P577
2013-01-01T00:00:00Z